Ad is loading...
Ad is loading...
HGHRX vs SHSAX
HGHRX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. SHSAX commentary
Nov 18, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Sell and SHSAX is a Sell.
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 7.78B vs. HGHRX (986M). SHSAX pays higher dividends than HGHRX: SHSAX (0.23) vs HGHRX (0.00). HGHRX was incepted earlier than SHSAX: HGHRX (18 years) vs SHSAX (25 years). HGHRX is a more actively managed with annual turnover of: 32.00 vs. SHSAX (29.00). HGHRX has a lower initial minimum investment than SHSAX: HGHRX (0) vs SHSAX (1000). HGHRX annual gain was more profitable for investors over the last year : 10.62 vs. SHSAX (7.48). SHSAX return over 5 years is better than : 6.66 vs. HGHRX (1.11).
| HGHRX | SHSAX | HGHRX / SHSAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 18 years | 25 years | - |
| Gain YTD | 1.952 | 2.599 | 75% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 986M | 7.78B | 13% |
| Annual Yield % from dividends | 0.00 | 0.23 | - |
| Returns for 1 year | 10.62 | 7.48 | 142% |
| Returns for 3 years | -17.00 | -13.30 | 128% |
| Returns for 5 years | 1.11 | 6.66 | 17% |
| Returns for 10 years | -0.47 | 31.58 | -1% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SROI | 29.81 | N/A | N/A |
| Calamos Antetokounmpo Global Sus Eqs ETF | |||
| REVS | 26.24 | -0.01 | -0.05% |
| Columbia Research Enhanced Value ETF | |||
| TLH | 101.70 | -0.16 | -0.16% |
| iShares 10-20 Year Treasury Bond ETF | |||
| CZA | 109.48 | -0.45 | -0.41% |
| Invesco Zacks Mid-Cap ETF | |||
| ROM | 67.96 | -3.57 | -4.99% |
| ProShares Ultra Technology | |||